Odisha sees surge in fake medicines; 4 suppliers blacklisted in 3 years

Bhubaneswar: Odisha registered a huge surge in counterfeit or fake medicines in a past few years, putting lives of many patients at risk.

This was revealed from a statement by Odisha Health & Family Welfare Minister Dr. Mukesh Mahaling in Assembly today.

According to reports, the fake medicines were supplied from other places like Uttar Pradesh, Madhya Pradesh, Kolkata and Hyderabad.

Replying to a query by BJP’s Dharamgarh MLA Sudhir Ranjan Pattjoshi, the Minister stated that 103 medicines procured by Odisha State Medical Corporation were found substandard and 4 suppliers have been blacklisted in past 3 years.

“Total 45 tablets and Ringer’s Lactate including Zinc Suplphate, Sodium Lactate were declared as substandard in 2022-23 FY, 32 medicines were found falsified during 2023-24 FY and 26 fake medicines were found fake in 2024-25 FY,” Dr. Mahaling stated.

As part of measure to prevent supply of counterfeit medicines in the state, the government has blacklisted four suppliers so far. The blacklisted pharmaceutical firms were LA CHEMICO Pvt Ltd, Kolkata; Swaroop Pharmaceutical Pvt Ltd, Uttar Pradesh; Ives Drugs India Pvt Ltd, Madhya Pradesh; and Alliance Biotech, Hyderabad, he said.

Related Posts

Unapproved drops for dry eyes pose risks: Govt

NEW DELHI: Flagging that certain yet-to-be-approved dry eye relief drops are being sold in the market, the central drugs regulator has asked states to cancel any permissions granted for these…

Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

The global conversation around obesity and type 2 diabetes management has shifted dramatically in recent years, largely due to the rise of GLP-1 receptor compounds. Among them, semaglutide has emerged…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Unapproved drops for dry eyes pose risks: Govt

Unapproved drops for dry eyes pose risks: Govt

Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward

Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward

Govt highlights multi-layer framework to curb misleading advertisements

Govt highlights multi-layer framework to curb misleading advertisements

Major breakhthrough: Sonbhadra cops nab codeine syrup racket handler in Bengal

Major breakhthrough: Sonbhadra cops nab codeine syrup racket handler in Bengal

Study finds rising resistance to a last-resort antibiotic in Africa

Study finds rising resistance to a last-resort antibiotic in Africa